BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #22 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 23 Aug 2026 07:27 UTC
#1099 of 1208 overall by tension · #22 of 26 in Health & Pharma
6 Aligned
The Balanced
Analysis

German biotech with unstable metrics (C=46 vs B=52), but stock surge +26.62% shows market sees product beyond buzz. Positive sentiment (0.30) tied to pipeline, not PR.

IN THE NEWS (90 articles this week)
BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. - Barron's
BioNTech’s rally on Moderna trial win likely to fade, Leerink says - Seeking Alpha
The mRNA wars are escalating with new claims from Arbutus - JUVE Patent
Cultural Score
46 / 100
Business Score
52 / 100
TREND
TENSION▁▁▁▁▁▁▁▃▁▁▁▁▂▁
CULTURAL▃▄▄▄▄▄▄▆▄▄▄▃▆▄
BUSINESS▂▃▃▃▃▃▃▃▃▃▃▃▄▄
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 31/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 30/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
STOCK DATA
Price$116.57
30d Change+26.6%
Market Cap$29.3B
Profit Margin-63.6%
BRANDS LIKE THIS
Walgreens
C:46 B:54 T:8
Strava
C:40 B:46 T:6
Headspace
C:46 B:55 T:9
Bluesky
C:46 B:52 T:6
Li Auto
C:46 B:52 T:6
SHARE
BioNTech's tension is 6. Commerce outpacing culture. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman